Revenue Split. For so long as Pharmasset is detailing to Non-Target Providers, Pharmasset shall receive a royalty on Net Sales attributable to prescriptions from the Non-Target Providers, to be set forth in the Co-Promotion Agreement, in addition to the royalties otherwise provided for under Article 5 of the Collaboration Agreement. Pharmasset may also detail Targeted Providers without additional compensation, as otherwise provided for under Article 5 of the Collaboration Agreement. [***] .
Appears in 2 contracts
Sources: Collaboration Agreement (Pharmasset Inc), Collaboration Agreement (Pharmasset Inc)
Revenue Split. For so long as Pharmasset is detailing to Non-Target Providers, Pharmasset shall receive a royalty on Net Sales attributable to prescriptions from the Non-Target Providers, to be set forth in the Co-Promotion Agreement, in addition to the royalties otherwise provided for under Article 5 of the Collaboration Agreement. Pharmasset may also detail Targeted Providers without additional compensation, as otherwise provided for under Article 5 of the Collaboration Agreement. [***] ].
Appears in 1 contract